News

Venaxis Announces APPY1 Test Clinical Trial Results to be Presented at ACEP14

Venaxis, Inc. today announced that results of the company’s pivotal APPY1 clinical trial will be presented by Dr. David S. Huckins, M.D., Lead Principal Investigator, at the American College of Emergency Physicians Scientific Assembly 2014 (ACEP14).  Read more…



Venaxis to Present at September Investor Conferences

Venaxis, Inc. today announced it will present at three upcoming investor conferences: the Rodman & Renshaw 16th Annual Global Investment Conference being held in New York on September 8-10, 2014, the Aegis Capital 2014 Healthcare & Technology Conference being held in Las Vegas on September 10-13, 2014, and the 5th Annual Craig-Hallum Alpha Select Conference being held in New York on September 18, 2014.  Read more…



Venaxis Announces Regulatory and Market Development Progress

Venaxis, Inc. will host an investor conference call to discuss business updates, including discussion on the progress of its APPY1 FDA submission, commercial and marketing progress and next-generation product development.  Read more…